Interactive effects of methylphenidate and alcohol on discrimination, conditioned place preference and motor coordination in C57BL/6J mice

Psychopharmacology

Volumn 225, Issue 3, 2013, Pages 613-625

  Griffin III, William C ^a   McGovern, Robin W ^b   Bell, Guinevere H ^c   Randall, Patrick K ^a   Middaugh, Lawrence D ^a   Patrick, Kennerly S ^c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b WESTMINSTER COLLEGE   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Ataxia; Drug drug interaction; Ethanol; Interoceptive; Methylphenidate; Mouse; Psychostimulant; Reinforcement

Indexed keywords

ALCOHOL; ETHYLPHENIDATE; METHYLPHENIDATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; BRAIN TISSUE; CHEMICAL INTERACTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DISCRIMINATION; GAS CHROMATOGRAPHY; LOCOMOTION; MALE; MOTOR COORDINATION; MOUSE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; ROTAROD TEST; TASK PERFORMANCE;

ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING (PSYCHOLOGY); DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ETHANOL; MALE; METHYLPHENIDATE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY;

EID: 84873703607     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-012-2849-z     Document Type: Article

References (53)

1. Barrett SP, Pihl RO (2002) Oral methylphenidate-alcohol co-abuse. J Clin Psychopharmacol 22(6):633-634
2. Barrett SP, Darredeau C, Pihl RO (2006) Patterns of simultaneous polysubstance use in drug using university students. Hum Psychopharmacol 21(4):255-263
3. Becker HC, Baros AM (2006) Effect of duration and pattern of chronic ethanol exposure on tolerance to the discriminative stimulus effects of ethanol in C57BL/6J mice. J Pharmacol Exp Ther 319(2):871-878
4. Bell GH, Griffin WC 3rd, Patrick KS (2011a) Oral and transdermal dl-methylphenidate-ethanol interactions in C57BL/6J mice: potentiation of locomotor activity with oral delivery. Pharmacol Biochem Behav 100(2):264-270
5. Bell GH, Novak AJ, Griffin WC 3rd, Patrick KS (2011b) Transdermal and oral dl-methylphenidate-ethanol interactions in C57BL/6J mice: transesterification to ethylphenidate and elevation of d-methylphenidate concentrations. J Pharm Sci 100(7):2966-2978
6. Berridge CW, Devilbiss DM, Andrzejewski ME, Arnsten AF, Kelley AE, Schmeichel B et al (2006) Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry 60(10):1111-1120
7. Biederman J, Faraone SV (2005) Attention-deficit hyperactivity disorder. Lancet 366(9481):237-248
8. Biederman J, Spencer T (2002) Methylphenidate in treatment of adults with Attention-Deficit/Hyperactivity Disorder. J Atten Disord 6(Suppl 1):S101-S107
9. Crissman AM, Studders SL, Becker HC (2004) Tolerance to the discriminative stimulus effects of ethanol following chronic inhalation exposure to ethanol in C57BL/6J mice. Behav Pharmacol 15(8):569-575
10. Cunningham CL, Patel P (2007) Rapid induction of Pavlovian approach to an ethanol-paired visual cue in mice. Psychopharmacol 192(2):231-241
11. Cunningham CL, Patel P, Milner L (2006) Spatial location is critical for conditioning place preference with visual but not tactile stimuli. Behav Neurosci 120(5):1115-1132
12. Darredeau C, Barrett SP, Jardin B, Pihl RO (2007) Patterns and predictors of medication compliance, diversion, and misuse in adult prescribed methylphenidate users. Hum Psychopharmacol 22(8):529-536
13. dela Peńa IC, Ahn HS, Choi JY, Shin CY, Ryu JH, Cheong JH (2011) Methylphenidate self-administration and conditioned place preference in an animal model of attention-deficit hyperactivity disorder: the spontaneously hypertensive rat. Behav Pharmacol 22(1):31-39
14. dela Peña I, Lee JC, Lee HL, Woo TS, Lee HC, Sohn AR et al (2012) Differential behavioral responses of the spontaneously hypertensive rat to methylphenidate and methamphetamine: lack of a rewarding effect of repeated methylphenidate treatment. Neurosci Lett 514(2):189-193
15. Godfrey J (2009) Safety of therapeutic methylphenidate in adults: a systematic review of the evidence. J Psychopharmacol 23(2):194-205
16. Griffin WC 3rd, Novak AJ, Middaugh LD, Patrick KS (2010) The interactive effects of methylphenidate and ethanol on ethanol consumption and locomotor activity in mice. Pharmacol Biochem Behav 95(3):267-272
17. Hasin DS, Stinson FS, Ogburn E, Grant BF (2007) Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 64(7):830-842
18. Jerlhag E (2008) The antipsychotic aripiprazole antagonizes the ethanol- and amphetamine-induced locomotor stimulation in mice. Alcohol 42(2):123-127
19. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE (2008). Monitoring the future national results on adolescent drug use: overview of key findings, 2007. edn, vol. NIH Publication No. 08-6418. National Institute on Drug Abuse, Bethesda, MD
20. Kamens HM, Crabbe JC (2007) The parallel rod floor test: a measure of ataxia in mice. Nat Protoc 2(2):277-281
21. Kamens HM, Phillips TJ, Holstein SE, Crabbe JC (2005) Characterization of the parallel rod floor apparatus to test motor incoordination in mice. Genes Brain Behav 4(4):253-266
22. Kroutil LA, Van Brunt DL, Herman-Stahl MA, Heller DC, Bray RM, Penne MA (2006) Nonmedical use of prescription stimulants in the United States. Drug Alcohol Depend 84(2):135-143
23. Kuczenski R, Segal DS (1997) Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J Neurochem 68(5):2032-2037
24. Kuczenski R, Segal DS (2001) Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine. J Pharmacol Exp Ther 296(3):876-883
25. Kuczenski R, Segal DS (2005) Stimulant actions in rodents: implications for attention-deficit/hyperactivity disorder treatment and potential substance abuse. Biol Psychiatry 57(11):1391-1396
26. LeVasseur NL, Zhu HJ, Markowitz JS, DeVane CL, Patrick KS (2008) Enantiospecific gas chromatographic-mass spectrometric analysis of urinary methylphenidate: implications for phenotyping. J Chromatogr B Anal Technol Biomed Life Sci 862(1-2):140-149
27. Mallonee E, Calvin S (2005). Emergency Department Visits Involving Underage Drinking 2004. The New DAWN Report 1-4
28. Manjanatha MG, Shelton SD, Dobrovolsky VN, Shaddock JG, McGarrity LG, Doerge DR et al (2008) Pharmacokinetics, dose-range, and mutagenicity studies of methylphenidate hydrochloride in B6C3F1 mice. Environ Mol Mutagen 49(8):585-593
29. Markowitz JS, Patrick KS (2008) Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter? J Clin Psychopharmacol 28(3 Suppl 2):S54-S61
30. Markowitz JS, Logan BK, Diamond F, Patrick KS (1999) Detection of the novel metabolite ethylphenidate after methylphenidate overdose with alcohol coingestion. J Clin Psychopharmacol 19(4):362-366
31. Markowitz JS, DeVane CL, Boulton DW, Nahas Z, Risch SC, Diamond F et al (2000) Ethylphenidate formation in human subjects after the administration of a single dose of methylphenidate and ethanol. Drug Metab Dispos 28(6):620-624
32. Martin CS (2008) Timing of alcohol and other drug use. Alcohol Res Health 31(2):96-99
33. McCabe SE, Teter CJ, Boyd CJ, Guthrie SK (2004) Prevalence and correlates of illicit methylphenidate use among 8th, 10th, and 12th grade students in the United States, 2001. J Adol Health 35(6):501-504
34. McCabe SE, Cranford JA, Morales M, Young A (2006) Simultaneous and concurrent polydrug use of alcohol and prescription drugs: prevalence, correlates, and consequences. J Stud Alcohol 67(4):529-537
35. McGovern RW, Middaugh LD, Patrick KS, Griffin WC 3rd (2011) The discriminative stimulus properties of methylphenidate in C57BL/6J mice. Behav Pharmacol 22(1):14-22
36. Middaugh LD, Boggan WO, Randall CL (1987) Stimulatory effects of ethanol in C57BL/6 mice. Pharmacol Biochem Behav 27(3):421-424
37. Middaugh LD, Bao K, Shepherd CL (1992) Comparative effects of ethanol on motor activity and operant behavior. Pharmacol Biochem Behav 43(2):625-629
38. Nocjar C, Middaugh LD, Tavernetti M (1999) Ethanol consumption and place-preference conditioning in the alcohol-preferring C57BL/6 mouse: relationship with motor activity patterns. Alcohol Clin Exp Res 23(4):683-692
39. Okie S (2006) ADHD in adults. N Engl J Med 354(25):2637-2641
40. Patrick KS, Kilts CD, Breese GR (1981) Synthesis and pharmacology of hydroxylated metabolites of methylphenidate. J Med Chem 24(10):1237-1240
41. Patrick KS, Caldwell RW, Ferris RM, Breese GR (1987) Pharmacology of the enantiomers of threo-methylphenidate. J Pharmacol Exp Ther 241(1):152-158
42. Patrick KS, Williard RL, VanWert AL, Dowd JJ, Oatis JE Jr, Middaugh LD (2005) Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol. J Med Chem 48(8):2876-2881
43. Patrick KS, Straughn AB, Minhinnett RR, Yeatts SD, Herrin AE, DeVane CL et al (2007) Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther 81(3):346-353
44. Schechter MD (1988) Advantages and disadvantages of a rapid method to train drug discrimination. Pharmacol Biochem Behav 31(1):239-242
45. Stolerman IP, Childs E, Ford MM, Grant KA (2011) Role of training dose in drug discrimination: a review. Behav Pharmacol 22(5-6):415-429
46. Szumlinski KK, Price KL, Frys KA, Middaugh LD (2002) Unconditioned and conditioned factors contribute to the 'reinstatement' of cocaine place conditioning following extinction in C57BL/6 mice. Behav Brain Res 136(1):151-160
47. Teter CJ, McCabe SE, LaGrange K, Cranford JA, Boyd CJ (2006) Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy 26(10):1501-1510
48. Trezza V, Damsteegt R, Vanderschuren LJMJ (2009) Conditioned place preference induced by social play behavior: parametrics, extinction, reinstatement and disruption by methylphenidate. Eur Neuropsychopharmacol 19(9):659-669
49. Williard RL, Middaugh LD, Zhu HJ, Patrick KS (2007) Methylphenidate and its ethanol transesterification metabolite ethylphenidate: brain disposition, monoamine transporters and motor activity. Behav Pharmacol 18(1):39-51
50. Wooters TE, Walton MT, Bardo MT (2011) Oral methylphenidate establishes a conditioned place preference in rats. Neurosci Lett 487(3):293-296
51. Zhu HJ, Patrick KS, Yuan HJ, Wang JS, Donovan JL, DeVane CL et al (2008) Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis. Am J Hum Genet 82(6):1241-1248
52. Zhu HJ, Patrick KS, Markowitz JS (2011a) Enantiospecific determination of dl-methylphenidate and dl-ethylphenidate in plasma by liquid chromatography-tandem mass spectrometry: application to human ethanol interactions. J Chromatogr B Anal Technol Biomed Life Sci 879(11-12):783-788
53. Zhu J, Spencer TJ, Liu-Chen L-Y, Biederman J, Bhide PG (2011b) Methylphenidate and μ opioid receptor interactions: a pharmacological target for prevention of stimulant abuse. Neuropharmacology 61(1-2):283-292